Ritu Banerjee Archives

Three elected to the American Pediatric Society

Jan. 5, 2023—Three physicians in the Vanderbilt Department of Pediatrics have been elected to the American Pediatric Society.

Improving awareness and understanding of antimicrobial resistance is crucial

Nov. 17, 2022—The Vanderbilt Antimicrobial Stewardship Program provides oversight of antimicrobial therapies for both inpatient and outpatient populations.

Rise seen in parechovirus cases among children

Aug. 11, 2022—Doctors at Vanderbilt are seeing an unusually high number of young patients infected with a virus called parechovirus.

Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection.

Teen shares his battle with MIS-C following COVID-19 infection

Mar. 7, 2022—Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection.

Vanderbilt Antimicrobial Stewardship Program personnel include (front row, from left) Chelsea Gorsline, MD, Sophie Katz, MD, Gowri Satyanarayana, MD. Not pictured, Ritu Banerjee, MD, PhD, Jessica Gillon, PharmD, (back row, from left) Milner Staub, MD, George Nelson, MD, Ben Ereshefsky, PharmD, and Jeff Frieberg, MD, PhD.

VUMC recognized for antimicrobial drug stewardship efforts

Feb. 17, 2022—by Paul Govern The Infectious Diseases Society of America (IDSA) has designated Vanderbilt University Medical Center an Antimicrobial Stewardship Center of Excellence. Antimicrobial stewardship is the effort to measure and improve how antibiotics and other antimicrobial drugs are prescribed by clinicians and used by patients. Bacteria, viruses, fungi and other pathogens can become resistant to...

Ritu Banerjee, MD, PhD, and her colleagues are studying a new way to determine whether antibiotics will be effective against certain bacterial infections.

VUMC awarded CDC funding to combat antimicrobial resistance, infectious diseases

Dec. 7, 2021—Vanderbilt has partnered with the CDC to combat the crisis of antimicrobial resistance and other healthcare threats through a newly created Global Action in Healthcare Network (GAIHN).

Study explores impact of COVID-19 on children

Oct. 21, 2021— by Jessica Pasley In a large, prospective study of children with COVID-19 infection at Monroe Carell Jr. Children’s Hospital at Vanderbilt, researchers found that most children experienced brief and mild illness with a small minority requiring hospitalization. During the onset of the pandemic, medical teams were not sure how the infection would impact children....

Some children with COVID-19 may experience rare inflammatory syndrome

Sep. 10, 2020—With cases of COVID-19 increasing among young children and adolescents in Tennessee, pediatric infectious disease experts at Monroe Carell Jr. Children’s Hospital at Vanderbilt have started to see cases of a mysterious illness believed to be connected to COVID-19, known as multi-inflammatory syndrome in children (MIS-C).

New test assists physicians with quicker treatment decisions for sepsis

Oct. 3, 2019—Rapid blood culture diagnostics for patients with bacterial bloodstream infections delivered final results in 12 hours versus the two to three days required for conventional testing.

Program seeks to optimize appropriate use of antibiotics

Nov. 10, 2016—Relying on a core team of physicians and pharmacists, the Vanderbilt Antimicrobial Stewardship Program (VASP) is seeking to ensure optimum use of antibiotics and other antimicrobial drugs at Vanderbilt University Medical Center (VUMC).